Skip to content

KYNTRA BIO, INC.

KYNB · XNAS

CIK 921299fmd_05DRCG3Z1T1FMME1WFV404KDHFManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2013 to Jun 30, 2026, 51 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading